Luczo Dragon IndyCar Carries 'Eyes on the Road' Logo to Prevent Blindness t... ( BOSTON and INDIANAPOLIS May 20 /-...)

Luczo Dragon IndyCar Carries 'Eyes on the Road' Logo to Prevent Blindness to Indy 500

Date:5/20/2008

BOSTON and INDIANAPOLIS, May 20 /PRNewswire/ -- On May 25, one bright yellow IndyCar, the Number 12 Symantec Dallara Honda, will be racing to win the Indianapolis 500 bearing the symbol of a campaign to fight blindness -- Eyes on the Road. By emblazoning their car on both sides with the logo of Eyes on the Road, http://www.eyesontheroad.org, IndyCar owners Jay Penske and Steve Luczo of Luczo Dragon Racing and its driver, IndyCar Series veteran Tomas Scheckter of South Africa, add their support to a cause of great importance to all people and especially to anyone who loves to drive.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080520/NETU096 )

Eyes on the Road is the brain child of Indy 500 fan and trucking enthusiast Mark Harter of Indianapolis, who is legally blind, and consists of a partnership between Schepens Eye Research Institute in Boston and Truck.Net, the nation's leading trucking industry internet portal. Its purpose: to increase awareness of and funding for research to prevent and cure blindness.

"When we heard from Mark about the work that he and the Schepens were doing together to fight blindness, we were tremendously inspired and wanted to do what we could to help," says Jay Penske, who with partner, Steve Luczo, are already dedicated philanthropists who commit 50 percent of their winnings to charities each year.

Harter, who has idolized Penske's father Roger since childhood, reached out to the younger Penske in February with the hope that an IndyCar could be part of the Eyes on the Road initiative.

"Race car drivers are natural advocates for our mission," says Harter. "Like truckers, their ability to drive depends on great eyesight. We are thrilled that Luczo Dragon Racing agreed to bring our message to the racing community and the public."

The 32-year-old Harter, a
'/>"/>

SOURCE Schepens Eye Research Institute
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Dragon Achieved Solid Increase in Sales and Profits from Continuing Operations for Q3
2. Dragon Sells EPO Business; Focus on Antibiotic Core Business
3. Chinas biotech industry: An Asian dragon is growing
4. Dragons of hope: Boat racing improves lives of breast cancer survivors
5. Revolabs xTag(TM) Wireless Microphone Now Offered as a Total Solution With Dragon(R) NaturallySpeaking(R) Medical Software from Nuance
6. Mindray to Present at the Oppenheimer 2nd Annual China Dragon Call Conference and 2008 Citi Investment Research Global Healthcare Conference
7. Obesity During Pregnancy Carries Bigger Price Tag
8. A Drug That Carries a Lower Risk of Weight Gain Than AstraZenecas Seroquel and Has Antimanic and Antidepressant Effects Would Earn a 30 Percent Patient Share in Bipolar Disorder Treatment
9. Childhood vaccination may protect adult eyes
10. Scientists Spot Eyes Motion Sensors
11. An eye for an eye: using stem cells to treat damaged eyes and a rare skin disorder

Post Your Comments:

(Date:12/14/2009)... physical, mental functioning , , , MONDAY, Dec. 14 (HealthDay ... tend to live longer than those who look older ... finding came from research that involved 1,826 Danish twins, ... cognitive tests and then had their faces photographed. Three ... the age they perceived the participants to be. Twins ...

(Date:12/14/2009)... Professional HealthCare at Home now provides in-home caregivers who have ... provides home nursing, rehab therapy, caregiver, and hospice services to ... ... Walnut Creek, CA (PRWEB) December 14, 2009 -- Professional ... of total home health care, including nursing, rehab, personal caregiver ...

(Date:12/14/2009)... Josie Raper, a 29 year-old mother from Phoenix who lost ... help of the Dr. Siegal,s COOKIE DIET® six-cookies-a-day weight-loss program ... segment on NBC,s Today Show. The Joy Fit Club feature, ... month and salutes those who have lost at least 100 ... it off for two years. ,, "The first time I ...

(Date:12/14/2009)... 2009 Only about one in 2,000 people in the ... one of the unfortunate few. , Ms. Wilcox,s tumor was ... even those problems were mistaken for blocked sinuses. , "For ... of my nose," recalled the resident of Goldthwaite, a town ... Country. "I felt a fullness, but I didn,t take that ...

(Date:12/14/2009)... ROCHESTER, Minn. -- A recent study, published in the ... new survival data for the blood disorder myelofibrosis. This ... patients with primary myelofibrosis. , Myelofibrosis is a ... blood cells. The result is extensive scarring in the ... often, an enlarged spleen and liver. , "In ...

Breaking Medicine News(10 mins):Health News:Looking Younger Than Your Age May Mean Longer Life 2 Health News:Caregivers with Professional HealthCare at Home Now Certified by the Alzheimer's Association 2 Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 2 Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 3 Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 4 Health News:Minimally invasive surgery removes sinus tumor without facial disfiguration 2

[0] Looking Younger Than Your Age May Mean Longer Life [0] Caregivers with Professional HealthCare at Home Now Certified by the Alzheimer's Association [0] Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club [0] Minimally invasive surgery removes sinus tumor without facial disfiguration [0] Mayo Clinic Proceedings: Researchers find evidence of survival gains in bone marrow disease

... The Foundation,for Taxpayer and Consumer Rights (FTCR) said today ... on what hospitals will pay in,fees for access to ... Yesterday, FTCR sent a letter to legislative leaders ... any limits placed on how much,individuals and employees will ...

... 6 The University of,Texas at Austin,s Center ... "Length of Prescription Drug Payment Times by Medicare,Part ... slow,reimbursement pharmacies have endured with Medicare Part D ... the Senate and House to,pass S.1954, the Pharmacy ...

... CLEVELAND, Sept. 6 Cleveland Clinic Press,( ... ( http://www.clevelandclinic.org/ ), has just released "Write ... Journal Writing" by Dr.,Sheppard B. Kominars ( ... powerful insights and techniques for personal transformation ...

... N.J., Sept. 6 Par,Pharmaceutical Companies, Inc. (NYSE: ... Commission its 2006 Annual Report on Form 10-K. The,filing ... due to the work,involved in restating its consolidated financial ... year. Par intends to file its,Form 10-Q for the ...

... Responding to increasing,needs of children and parents, as ... it,serves, Regional Center of Orange County (RCOC) has ... it provides to families,struggling to raise children with ... launched a program to ensure that,parents having difficulty ...

... the patient real benefit, too , THURSDAY, Sept. 6 ... disease report better physical health if they participate in ... the health of spouse caregivers through counseling and support ... who are in poor health are more likely to ...

Hospitals Agree to Pay Fees in Exchange for More Income, but Consumers in the Dark About What They'll be Charged Under Nunez Plan University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix Cleveland Clinic Press Releases Journal-Writing Book 'Write for Life: Healing Body, Mind, and Spirit Through Journal Writing' by Sheppard B. Kominars, Ph.D.Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs Counseling Boosts Alzheimer's Caregivers' Health

(Date:12/14/2009)... Calif., Dec. 14 The Roberts ... today released the analysis of social responsibility ... world-wide. The report contains a compilation of ... environmental and social reporting of the companies. ... and performance for both environmental and social ...

(Date:12/14/2009)... 14 According to Millennium Research ... technology market intelligence, Japan,s complex regulatory environment ... a significant lag in peripheral vascular stenting ... other developed nations. MRG,s new ... report finds, however, that recent indication-specific ...

(Date:12/14/2009)... INDIANAPOLIS, Dec. 14 The ... RELPREVV (olanzapine) For Extended Release Injectable Suspension for ... and Company (NYSE: LLY ) announced ... the delivery of olanzapine for up to four ... short-acting formulations, long-acting formulations of antipsychotics allow for ...

Breaking Medicine Technology:New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 2 New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 3 Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 2 Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 3 FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2 FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3 FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4 FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5 FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6 FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7 FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8 Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 1 Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 2 Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 3 Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 4 Healthcare Debate 3A One Citizens Call for Calm Catches On 56077 1 Healthcare Debate 3A One Citizens Call for Calm Catches On 56077 2 Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 1 Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 2 Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 3

[0] New Report Grades Sustainability Reporting of Top Pharmaceutical Companies [0] Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 [0] FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults

... 8, 2007 - Hollis-Eden,Pharmaceuticals, Inc. (NASDAQ:HEPH) today ... 07, 2007, by the Department of,Health & ... candidate for the treatment of Acute Radiation ... no longer in the,competitive range for the ...

... TRIANGLE PARK, N.C., Mar 8, 2007 (CCNMatthews ... (TSX:AHX)(AMEX:ADH), a,biopharmaceutical company with a broad portfolio ... Dr. Antonella,Perotti, MD, Istituto Nazionale dei Tumori ... Phase Ib/II study,of single-agent ADH-1, will present ...

Other Medicine Technology:Hollis-Eden Announces Cancellation of Acute Radiation Syndrome RFP,by Department of Health and Human Services 2 Hollis-Eden Announces Cancellation of Acute Radiation Syndrome RFP,by Department of Health and Human Services 3 Hollis-Eden Announces Cancellation of Acute Radiation Syndrome RFP,by Department of Health and Human Services 4 Hollis-Eden Announces Cancellation of Acute Radiation Syndrome RFP,by Department of Health and Human Services 5 Data From Adherex's European Phase Ib/II Trial of ADH-1 to be,Presented at International Symposium on Targeted Anticancer,Therapies 2 Data From Adherex's European Phase Ib/II Trial of ADH-1 to be,Presented at International Symposium on Targeted Anticancer,Therapies 3

Hollis-Eden Announces Cancellation of Acute Radiation Syndrome RFP,by Department of Health and Human Services Data From Adherex's European Phase Ib/II Trial of ADH-1 to be,Presented at International Symposium on Targeted Anticancer,Therapies

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

Medicine Products:

Flexeril FK506 Fiorinal Fibronectin Aggregates IgA, ELISA

Luczo Dragon IndyCar Carries 'Eyes on the Road' Logo to Prevent Blindness t...( BOSTON and INDIANAPOLIS May 20 /-...),Health